background image

Paid Clinical Trials Des Moines

Discover 237 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: Des Moines IA, Oklahoma City OK, Austin TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting
Active & Responsive

VK2735 for Weight Management Phase 3

for
Weight Loss
Location: West Des Moines IA, Omaha NE, Kansas City MO,
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07104500

Phase3, Recruiting
Active & Responsive

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

for
Diabetes Mellitus, Type 1
Location: West Des Moines IA, Englewood CO, Mesquite TX,
Sponsor: vTv Therapeutics

Sex: All

Age: 18+

Code: NCT06334133

Phase3, Recruiting
Active & Responsive

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

for
Large B-cell Lymphoma
Location: Waukee IA, Rochester MN, Westwood KS, Minneapolis MN,
Sponsor: Celgene

Sex: All

Age: 18 - 70+

Code: NCT06356129

Phase3, Recruiting
Active & Responsive

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Waukee IA, Fort Sam Houston TX, Silver Spring MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05572515

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Des Moines IA, Iowa City IA, Omaha NE, Rochester MN,
Sponsor: Children's Oncology Group

Sex: All

Age: 365 - 30

Code: NCT03126916

Phase3, Recruiting

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.

for
Chronic Lymphocytic Leukemia
Location: Des Moines IA, Omaha NE, Grand Island NE, Milwaukee WI,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06524375

Phase2, Recruiting

Remote Ischemic Conditioning Using the autoRIC

for
Ischemia-Reperfusion Injury
Location: Des Moines IA, Kansas City MO, West Bloomfield MI,
Sponsor: CellAegis US, Inc.

Sex: All

Age: 18+

Code: NCT03318575

Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Des Moines IA, Omaha NE, Albert Lea MN, Lincoln NE,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Des Moines IA, Kansas City MO, Springfield IL, Dyer IN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting